Analysis of clinical safety in the Allergy Units of the Valencian Community
DOI:
https://doi.org/10.23938/ASSN.0027Keywords:
Allergy. Ambulatory care. Clinical safety. Health services. Hospital outpatient clinic.Abstract
The introduction of new diagnostic and therapeutic procedures involving allergen exposure may increase the risk of allergic reactions. We designed and distributed an anonymous questionnaire among the allergy units of the Valencian Community in order to collect information on measures to ensure clinical safety. Twelve hospital outpatient clinics and 8 ambulatory care centres reported similar patterns of activities, including the use of critical care units, emergency rooms or day hospitals for higher risk techniques. The provision of security-related instruments is broader in hospital outpatient clinics and included: oxygen (91.7%), pulse oximeter (75.0%) or vital signs monitor (8.3%), resuscitation material (91.7%) and defibrillator (83.3%). The response time for emergencies is set in 50% of clinics. The resuscitation material is systematically reviewed and informed consent signed. Security is more limited in ambulatory care centres. It is necessary to set down the conditions for clinical safety in allergology.
Downloads
References
Estrategia de seguridad del paciente del Sístema nacional de salud período 2015-2020. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad 2016. http://publicacionesoficiales.boe.es/. Consultado el 16 de diciembre de 2016.
DOMÍNGUEZ-ORTEGA J, RUIZ J, CHIVATO T, DE LA HOZ B, ELICES A, IGLESIAS A et al. La alergología en el sistema sanitario público de la Comunidad de Madrid: Situación actual y oportunidades en el Sistema sanitario público del Siglo XXI. An Sist Sanit Navar 2014; 37: 317-327.
CATALÁ M, GÓMEZ A, OLLO B, GURPEGUI M, TALENS M. Seguridad de inmunoterapia con veneno de himenópteros en pauta agrupada. Perspectiva de enfermería. An Sist Sanit Navar 2009; 32: 409-412.
BUKANTZ SC, LOCKEY RF. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy. Clin Allergy Immunol 2004; 18 : 711-727.
MORAL VP, CARRILLO T, DELGADO J, ENTRENAS L, MORAGÓN EM, OLAGUIBEL JM et al. Debate multidisciplinar de expertos. Asma no controlada: causas, consecuencias y posibles soluciones. An Sist Sanit Navar 2016; 39: 357-370.
LICCARDI G, D'AMATO G, CANONICA GW, SALZILLO A, PICCOLO A, PASSALACQUA G. Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol 2006; 16: 75-78.
EPSTEIN TG, LISS GM, MURPHY-BERENDTS K, BERNSTEIN DI. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013). Ann Allergy Asthma Immunol 2016; 116: 354-359.
SWENDER DA, CHERNIN LR, MITCHELL C, SHER T, HOSTOFFER R, TCHEUREKDJIAN H. The rate of epinephrine administration associated with allergy skin testing in a suburban allergy practice from 1997 to 2010. Allergy Rhinol (Providence) 2012; 3: e55-e60.
DHAMI S, ZAMAN H, VARGA EM, STURM GJ MURARO A, AKDIS CA et al. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis. Allergy 2016; 6: 1-24.
FUENTES-APARICIO V, ALVAREZ-PEREA A, INFANTE S, ZAPATERO L, D’OLEO A, ALONSO-LEBRERO E. Specific oral tolerance induction in paediatric patients with persistent egg allergy. Allergol Immunopathol (Madrid) 2013; 41:143-150.
NURMATOV U, DHAMI S, ARASI S, PAJNO GB, FERNANDEZ-RIVAS M, MURARO A et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy 2017. doi: 10.1111/all.13124.
IGLESIAS A, HERNÁNDEZ E. Gestión clínica en Alergologia. En: Davila IJ, Jáuregui I, Olaguibel JM, Zubeldia JM editores. Tratado de alergología. Vol 1. 2a ed. Madrid: Ergon, 2015: 373-384.
PFAAR O, BACHERT C, BUFE A, BUHL R, EBNER C, ENG P et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the ProfesSíonal Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int 2014; 23: 282-319.
KOWALSKI ML, ANSOTEGUI I, ABERER W, AL-AHMAD M, AKDIS M, BALLMER-WEBER BK et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J 2016; 9:33.
Organización Mundial de la Salud. Segundo reto mundial por la seguridad del paciente: la cirugía segura salva vidas. Alianza mundial para la seguridad del paciente 2008. http://www.who.int/patientsafety/safesurgery/sssl_brochure_spanish.pdf. Consultado el 1 de febrero de 2017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
